论文部分内容阅读
目的:对卡介菌多糖联合阿昔洛韦治疗带状疱疹的疗效予以观察。方法:选取我院从2015年10月到2017年3月收治的40例带状疱疹患者,将其随机均分为对照组与治疗组,对对照组进行口服阿昔洛韦的治疗,对治疗组进行阿昔洛韦片口服联合肌肉注射卡介菌多糖的治疗,对比分析两组治疗的总有效率、起效时间、后遗神经痛发生率。结果:两组患者在治疗后的治疗总有效率、起效时间、后遗神经痛发生率均存在明显差异,并且P<0.05,差异具有统计学意义。结论:相比于对照组,治疗组在经过卡介菌多糖联合阿昔洛韦的治疗后,治疗效果较好,且没有特别严重的不良反应。
Objective: To observe the curative effect of BCG polysaccharide combined with acyclovir on shingles. Methods: Forty patients with herpes zoster who were treated in our hospital from October 2015 to March 2017 were randomly divided into control group and treatment group. Oral acyclovir was given to the control group, Group acyclovir oral administration of intramuscular BCG polysaccharide treatment, comparative analysis of the two groups of total effective rate of treatment, onset time, the incidence of post-natal neuralgia. Results: There was a significant difference in the total effective rate, the onset time and the incidence of postherpetic neuralgia between the two groups after treatment, and P <0.05, the difference was statistically significant. Conclusion: Compared with the control group, the treatment group after treatment with BCG polysaccharides combined with acyclovir treatment is better, and no particularly serious adverse reactions.